Jointly chaired by Professor Saijuan Chen (Academician of Chinese Academy of Engineering and Director of Shanghai Institute of Haematology) and Dr. Per Falk (Senior Vice President of Novo Nordisk A/S), the 2014 board meeting of Novo Nordisk China Haemophilia Research Fund was held in Shanghai in the morning of February 25, 2014. Other board members who were present included Drs. Yongqiang Zhao (Director of Haematology Department, Peking Union Medical College Hospital), Renchi Yang (Professor of Tianjin Institute of Haematology and Blood Diseases Hospital) and Xiaodong Xi (Professor of Shanghai Center for Translational Medicine); Drs. Soeren Bjoern (Vice President of Novo Nordisk), Boerge Diderichsen (Vice President of Novo Nordisk) and Kezhou Zhang (Vice President of Novo Nordisk China Co., Ltd.); as well as Professor Ming-Wei Wang, independent board member and Director of the National Center for Drug Screening. The participants reviewed the progresses made in the past year, discussed newly funded research projects and agreed upon the tasks to be accomplished in 2014. Professor Qiulan Ding (Secretary of the board) and Ms. Haoyan Cai (Project Manage of Novo Nordisk China Co., Ltd.) attended the meeting.